viru
internalis
initi
bind
specif
receptor
cellsurfac
culmin
hostcel
membran
penetr
deliveri
viral
genom
site
replic
mani
virus
membran
penetr
follow
viru
endocytosi
sever
differ
endocytosi
pathway
oper
mammalian
cell
deliv
cargo
distinct
intracellular
locat
clathrinmedi
endocytosi
cme
major
pathway
receptordepend
endocytosi
mani
cell
type
depend
adaptor
protein
complex
gtpase
dynamin
sever
import
accessori
molecul
includ
cme
deliv
cargo
acid
endosom
initi
earlyendosom
sort
transport
either
lateendosomeslysosom
degrad
recyclingendosom
recycl
back
cell
surfac
sever
acidactiv
virus
known
exploit
low
ph
within
vesicl
deriv
clathrin
pathway
trigger
capsid
uncoat
andor
membran
penetr
clathrinindepend
endocytosi
includ
caveola
pathway
depend
caveolin
lipidraft
cholesterol
cargo
internalis
caveola
deliv
neutral
ph
caveosom
caveosom
cargo
traffic
er
golgi
like
cme
caveolaemedi
uptak
requir
dynamin
inhibit
express
dominantneg
dn
mutant
number
virus
use
caveola
infect
much
knowledg
caveola
come
studi
simian
number
caveolinindepend
pathway
also
origin
lipidraft
novel
clathrin
raftindepend
process
also
identifi
pathway
differ
requir
cellular
protein
dynamin
flotillin
small
gtpase
cholesterol
specif
lipid
also
exploit
virus
infect
macropinocytosi
major
form
endocytosi
respons
major
fluidphas
uptak
number
cell
type
macropinocytosi
characteris
actindepend
reorganis
plasma
membran
form
macropinosom
morpholog
heterogen
vesicl
lack
coat
structur
macropinocytosi
constitut
mani
cell
type
other
requir
activ
growth
factor
contribut
significantli
antigen
present
specialis
antigen
present
cell
macropinocytosi
also
exploit
wide
rang
import
anim
pathogen
cell
invas
possibl
avoid
immun
surveil
investig
entri
rout
use
bluetongu
viru
serotyp
infect
bhk
cell
bluetongu
viru
btv
type
speci
genu
orbiviru
within
famili
reovirida
includ
mani
import
pathogen
man
anim
btv
exist
least
serotyp
etiolog
agent
bluetongu
sever
econom
import
haemorrhag
diseas
rumin
bluetongu
arthropodborn
primarili
transmit
suscept
anim
host
certain
speci
culicoid
bite
midg
btv
nonenvelop
consist
layer
protein
capsid
outercapsid
core
subcor
surround
genom
ten
linear
segment
doublestrand
rna
outer
capsid
form
two
viral
protein
inner
coreparticl
consist
coresurfac
layer
compos
surround
subcor
shell
compos
interact
host
cellsurfac
receptor
serv
virusattach
protein
involv
hostcel
membran
penetr
outer
capsid
protein
remov
cell
entri
transcript
activ
core
particl
releas
cytosol
viru
replic
occur
howev
coreparticl
also
infecti
right
demonstr
also
mediat
cell
attach
membran
penetr
possibl
distinct
mechan
viral
encod
protein
also
produc
infect
cell
involv
viru
replic
releas
progeni
viru
particl
infect
btv
acidactiv
requir
low
ph
within
endosom
disassembl
outer
viral
capsid
membran
penetr
btv
particl
describ
insid
endosom
appear
clathrinco
vesicl
recent
studi
conclud
entri
infect
vero
hela
cell
occur
via
cme
capsid
disassembl
membran
penetr
within
earlyendosom
describ
use
pharmacolog
dn
inhibitor
endocytosi
investig
entri
infect
bhk
cell
found
clathrin
pathway
major
entri
rout
use
infect
bhk
cell
instead
found
entri
mechan
share
certain
characterist
common
macropinocytosi
appear
deliv
viru
directli
late
endosom
compart
studi
extend
earlier
observ
show
btv
join
increas
number
virus
exploit
multipl
endocytosi
pathway
infecti
entri
babi
hamster
kidney
bhk
cell
clone
obtain
european
cell
cultur
collect
maintain
glasgow
minimum
essenti
medium
gmem
sigma
contain
foetal
bovin
serum
fb
autogen
bioclear
mm
glutamin
uml
penicillin
streptomycin
tryptos
phosphat
broth
solut
sigma
south
african
refer
strain
iah
refer
number
ictvdb
isol
access
number
grown
bhk
cell
gradient
purifi
accord
previous
publish
method
purifi
viru
store
presenc
sodiumnlauroylsarcosin
prevent
viru
aggreg
use
experi
virus
dilut
immedi
use
therebi
reduc
concentr
sodiumnlauroylsarcosin
show
cytotox
effect
rabbit
orab
guineapig
antibodi
produc
institut
anim
health
use
recombin
immunogen
respect
specif
antibodi
verifi
western
blot
purifi
infect
bhk
cell
lysat
use
uninfect
cell
neg
control
show
lack
crossreact
uninfect
bhk
cell
confoc
microscopi
mab
anticmyc
development
studi
hybridoma
bank
univers
iowa
mous
monoclon
antibodi
mab
lysosom
antigen
jean
gruenberg
univers
geneva
speci
specif
alexafluor
conjug
secondari
antibodi
invitrogen
filipin
cytochalasind
dynasor
monohydr
nethylnisopropyl
amilorid
eipa
sigma
ammonium
chlorid
concanamycina
fluka
latrunculina
alexafluor
label
human
transferrin
dextran
phalloidin
invitrogen
stock
solut
transferrin
dextran
made
gmem
ammonium
chlorid
steril
water
stock
solut
phalloidin
made
methanol
stock
solut
inhibitor
made
dimethyl
sulfoxid
dmso
appropri
equival
dilut
dmso
methanol
includ
mock
treatment
plasmid
express
cmyc
tag
harvey
mcmahon
mrc
cambridg
uk
plasmid
express
green
fluoresc
protein
gfp
tag
wt
dominantneg
dn
mark
mcniven
mayo
clinic
rochest
usa
plasmid
control
alexandr
benmerah
pari
descart
pari
franc
cell
seed
glass
coverslip
bdh
antibioticfre
cellcultur
medium
transfect
confluent
cell
transfect
optimem
invitrogen
use
ratio
plasmid
dna
lipofectamin
invitrogen
accord
manufactur
guidelin
cell
incub
h
transfect
medium
replac
antibioticfre
cellcultur
medium
cell
use
experi
h
posttransfect
cell
express
transgen
identifi
confoc
microscopi
transfect
effici
determin
gfp
cmyc
express
rang
entri
experi
transfect
cell
gmem
bound
cell
minut
unbound
viru
remov
wash
cell
place
gmem
initi
entri
specifi
inhibitor
ad
cell
h
viru
bind
step
remain
present
throughout
assay
entri
experi
end
time
indic
addit
paraformaldehyd
pfm
except
involv
transferrin
end
use
pfm
glutaraldehyd
input
viru
detect
use
antibodi
quantif
viru
uptak
cell
cytoplasm
label
btv
score
posit
experi
control
cell
show
viru
uptak
infect
transfect
cell
cell
inocul
multipl
infect
moi
infecti
viru
particl
per
cell
serumfre
medium
h
unbound
viru
remov
wash
gmem
cell
return
cell
cultur
medium
reduc
fb
inhibitor
cytochalasind
latrunculina
ad
cell
h
infect
cell
inocul
describ
also
presenc
inhibitor
mocktreat
cell
infect
absenc
inhibitor
h
incub
viru
cell
wash
gmem
remov
unbound
viru
return
cell
cultur
medium
reduc
fb
supplement
mm
ammonium
chlorid
control
effect
intracellular
viru
replic
inhibitor
also
ad
cell
immedi
viru
inoculum
remov
coincid
addit
ammonium
chlorid
experi
shown
figur
moi
bound
cell
minut
cell
wash
remov
unbound
viru
place
gmem
initi
infect
allow
addit
inhibitor
synchron
start
infect
concanamycina
ad
cell
note
time
use
pretreat
concanamycina
ad
h
addit
viru
remain
present
viru
bind
step
concanamycina
also
ad
cell
either
coincid
start
infect
ie
shift
cell
variou
time
infect
initi
infect
experi
end
h
addit
cold
pfm
minut
infect
cell
identifi
use
confoc
microscopi
antibodi
quantif
infect
cell
cytoplasm
label
btv
score
posit
abil
cell
intern
clathrin
pathway
determin
observ
transferrin
uptak
confoc
microscopi
cell
serum
starv
h
prior
addit
label
transferrin
gmem
time
indic
result
quantif
transferrin
uptak
cell
cytoplasm
label
transferrin
score
posit
label
dextran
mgml
ad
cell
describ
transferrin
experi
control
cell
show
transferrin
dextran
uptak
cell
fixat
pfm
cell
wash
pb
ph
sigma
permeabl
triton
sigma
phosphat
buffer
salin
pb
minut
use
mab
identifi
posit
compart
cell
permeabl
saponin
place
triton
minut
saponin
includ
subsequ
step
nonspecif
bind
site
block
block
buffer
ml
trisbuff
salin
supplement
mm
mm
normal
goat
serum
harlan
lab
sera
teleostean
gelatin
sigma
h
cell
wash
pb
incub
primari
antibodi
block
buffer
h
wash
pb
incub
appropri
speci
specif
alexafluor
conjug
secondari
antibodi
also
block
buffer
h
cell
wash
nuclei
label
dapi
sigma
minut
wash
coverslip
mount
vectashield
mount
medium
fluoresc
vector
laboratori
seal
clear
nail
varnish
transfect
cell
express
dynamin
construct
identifi
gfp
fusion
tag
transfect
cell
express
identifi
use
anticmyc
antibodi
goat
antimous
conjug
secondari
antibodi
posit
compart
label
use
mab
data
collect
sequenti
elimin
cross
talk
fluoresc
dye
leica
confoc
scan
laser
microscop
experi
involv
dual
label
viru
cellular
compart
specif
secondari
antibodi
target
primari
antibodi
confirm
show
lack
crossreact
nontarget
primari
antibodi
data
shown
singl
optic
section
middl
cell
cellular
cholesterol
visualis
nm
immedi
label
filipin
dilut
pb
minut
room
temperatur
label
actin
filament
cell
fix
permeabil
incub
label
phalloidin
dilut
block
buffer
minut
room
temperatur
experi
uptak
transferrin
viru
normalis
result
obtain
cell
express
control
wt
control
respect
overexpress
wt
inhibit
cme
use
control
therefor
experi
transferrin
viru
uptak
normalis
result
obtain
cell
nonexpress
popul
ie
nongreen
cell
similarli
infect
normalis
level
infect
cell
express
wt
cell
nonexpress
popul
respect
level
infect
inhibitortr
cell
normalis
level
infect
mocktreat
control
student
test
use
determin
statist
signific
report
infect
hela
vero
cell
use
cme
entri
investig
involv
clathrin
pathway
entri
infect
bhk
cell
use
delet
mutant
known
act
dn
inhibitor
cme
block
uptak
transferrin
bhk
cell
transient
transfect
express
control
known
control
interfer
clathrin
pathway
h
posttransfect
cell
incub
label
transferrin
minut
h
cell
fix
process
confoc
microscopi
fig
viru
detect
use
conjug
secondari
antibodi
cell
express
protein
identifi
gfp
cmyc
fusion
tag
respect
see
method
shown
green
figur
cell
score
transferrin
btv
uptak
describ
method
dn
protein
uptak
transferrin
btv
normalis
result
obtain
control
see
method
cell
express
frequenc
transferrin
uptak
reduc
compar
cell
express
control
fig
b
e
f
indic
block
clathrinmedi
endocytosi
similarli
frequenc
transferrin
uptak
reduc
cell
express
compar
cell
nonexpress
popul
fig
j
contrast
express
fig
g
h
fig
l
significantli
inhibit
viru
uptak
virtual
cell
express
dn
protein
pattern
viru
label
indistinguish
cell
express
control
cell
express
transgen
result
show
condit
clathrinmedi
uptak
transferrin
inhibit
taken
normal
bhk
cell
experi
requir
use
rel
high
concentr
allow
viru
detect
entri
rais
possibl
viru
may
forc
enter
cell
via
endocyt
pathway
normal
use
nonproduct
infect
therefor
also
investig
effect
express
infect
low
moi
encourag
viru
uptak
effici
rout
h
posttransfect
cell
incub
moi
h
cell
wash
remov
excess
viru
infect
continu
h
cell
fix
process
confoc
microscopi
cell
express
identifi
use
express
cmyc
tag
describ
infect
cell
identifi
use
rabbit
antibodi
bind
viral
protein
marker
viru
replic
conjug
secondari
antibodi
intens
area
label
detect
within
infect
cell
fig
n
cell
express
score
infect
indic
label
result
normalis
result
obtain
nonexpress
cell
popul
cell
express
frequenc
infect
similar
nonexpress
cell
popul
indic
inhibit
infect
fig
result
show
viru
uptak
cell
express
lead
infect
support
conclus
cme
major
pathway
use
entri
bhk
cell
btv
infect
known
depend
low
ph
within
endosom
concanamycina
potent
specif
inhibitor
vacuolar
proton
atpas
commonli
use
rais
endosom
ph
pretreat
bhk
cell
concanamycina
inhibit
infect
fig
confirm
requir
activ
endosom
acidif
similarli
concanamycina
ad
coincid
start
infect
ie
time
figur
strong
inhibitori
effect
also
seen
ad
start
infect
concanamycina
also
inhibitori
effect
infect
ad
h
infect
initi
frequenc
infect
reduc
compar
mock
treat
cell
fig
near
ident
result
obtain
use
ammonium
chlorid
place
concanamycina
data
shown
result
suggest
deliv
acid
endosom
much
slower
expect
uptak
cme
rais
endosom
ph
may
prevent
receptor
recycl
could
deplet
cell
surfac
attach
receptor
therebi
reduc
infect
howev
pattern
viru
uptak
concanamycina
treat
cell
detect
h
postuptak
confoc
microscopi
use
antibodi
indistinguish
mocktreat
cell
data
shown
indic
inhibitori
effect
concanamycina
infect
due
failur
viru
internalis
recent
shown
cargo
internalis
via
caveola
deliv
acid
earlyendosom
caveolaemedi
endocytosi
depend
integr
lipidraft
like
raft
mediat
endocyt
pathway
inhibit
cholesterol
deplet
effect
cholesterol
deplet
infect
investig
use
bind
extract
cholesterol
plasma
membran
bhk
cell
mocktreat
treat
h
cell
incub
filipin
bind
cholesterol
detect
fluoresc
microscopi
filipin
fluoresc
detect
plasma
membran
within
cytosol
mocktreat
cell
fig
contrast
although
fluoresc
detect
within
cytosol
intens
plasma
membran
fluoresc
gener
filipin
bind
greatli
reduc
indic
extens
select
cholesterol
deplet
cell
surfac
fig
treat
cell
also
infect
moi
h
presenc
drug
see
method
mocktreat
cell
infect
parallel
wash
cell
remov
excess
viru
drug
infect
continu
h
end
infect
cell
process
confoc
microscopi
use
detect
infect
cell
figur
show
pretreat
cell
inhibit
infect
compar
mocktreat
cell
result
show
cell
entri
mechan
use
infect
bhk
cell
requir
cholesterol
therefor
unlik
mediat
caveola
lipidraft
mediat
endocyt
pathway
involv
dynamin
entri
infect
investig
use
dn
mutant
aa
splice
variant
bhk
cell
transient
transfect
express
gfpwt
aa
gfpdn
aa
h
posttransfect
cell
incub
label
transferrin
minut
h
cell
fix
process
confoc
microscopi
fig
viru
detect
use
conjug
secondari
antibodi
cell
express
wt
identifi
gfp
fusion
tag
shown
green
cell
express
show
transferrin
uptak
lower
frequenc
cell
express
wt
construct
fig
indic
block
clathrinmedi
endocytosi
contrast
taken
normal
cell
express
fig
h
posttransfect
cell
also
infect
moi
h
cell
wash
remov
excess
viru
infect
continu
h
cell
fix
process
confoc
microscopi
infect
cell
identifi
use
rabbit
antibodi
describ
frequenc
infect
cell
express
normalis
level
infect
cell
express
wt
protein
figur
show
express
inhibit
infect
result
consist
obtain
use
support
conclus
enter
bhk
cell
use
clathrinindepend
pathway
furthermor
aa
splice
variant
also
inhibit
caveolaemedi
endocytosi
result
also
support
conclus
caveola
unlik
requir
viru
entri
infect
investig
role
dynamin
infect
bhk
cell
treat
gener
dynamin
inhibitor
dynasor
mocktreat
dynasoretr
cell
incub
label
transferrin
label
dextran
figur
show
repres
cell
dynasor
effect
inhibit
uptak
three
ligand
virtual
drug
treat
cell
n
cell
per
ligand
show
uptak
viru
transferrin
dextran
also
investig
effect
dynasor
infect
howev
experi
inconclus
h
drug
remov
cell
detach
coverslip
indic
delay
cytotox
effect
nevertheless
observ
dynasor
inhibit
entri
bhk
cell
show
entri
mechan
dynamin
depend
number
endocyt
process
depend
function
actin
dynam
therefor
determin
entri
bhk
cell
requir
actin
use
cytochalasind
disrupt
actin
filament
cell
mocktreat
treat
drug
success
disrupt
actin
filament
confirm
confoc
microscopi
label
cell
label
phalloidin
data
shown
mock
drugtreat
cell
allow
internalis
h
presenc
drug
cell
fix
process
confoc
microscopi
use
detect
input
viru
describ
figur
show
repres
cell
cytochalasind
effect
block
entri
btv
virtual
drugtreat
cell
n
cell
show
pattern
viru
label
shown
figur
contrast
figur
show
cytochalasind
inhibit
uptak
label
transferrin
label
dextran
result
show
uptak
bhk
cell
actindepend
confirm
transferrin
enter
cell
via
differ
mechan
cytochalasind
treat
cell
also
infect
h
presenc
drug
see
method
mocktreat
cell
infect
parallel
h
incub
viru
cell
wash
remov
excess
unbound
viru
inhibitor
infect
continu
h
end
infect
cell
process
confoc
microscopi
use
detect
infect
cell
effect
cytochalasind
actin
filament
revers
possibl
follow
drug
washout
viru
remain
bound
outsid
cell
result
actin
disrupt
may
caus
infect
therefor
ammonium
chlorid
ad
cultur
medium
immedi
viru
inoculum
cytochalasind
remov
ammonium
chlorid
membran
permeabl
weak
base
rapidli
rais
endosom
ph
ad
prevent
infect
event
viru
yet
enter
cell
undergon
acidinduc
membran
penetr
condit
infect
occur
period
cytochalasind
present
control
possibl
effect
intracellular
viru
replic
cytochalasind
also
ad
cell
immedi
viru
inoculum
remov
coincid
addit
ammonium
chlorid
condit
cytochalasind
inhibitori
effect
infect
interf
postentri
viru
replic
figur
show
pretreat
bhk
cell
cytochalasind
inhibit
infect
contrast
ad
viru
internalis
step
inhibitori
effect
seen
fig
similar
result
obtain
use
latrunculina
place
cytochalasind
fig
result
confirm
infecti
entri
bhk
cell
actin
depend
macropinocytosi
actin
depend
increasingli
recognis
import
cell
entri
rout
number
virus
macropinocytosi
also
depend
amiloridesensit
nah
exchang
inhibit
nethylnisopropyl
amilorid
eipa
eipa
previous
shown
inhibit
macropinocytosi
without
affect
endocyt
pathway
cme
figur
show
repres
cell
eipa
effect
inhibit
uptak
dextran
fig
fig
virtual
drug
treat
cell
show
uptak
dextran
viru
n
cell
count
ligand
contrast
eipa
inhibit
uptak
transferrin
fig
virtual
cell
show
transferrin
uptak
n
cell
count
result
also
suggest
entri
may
mediat
macropinocytosi
macropinocytosislik
mechan
addit
eipa
block
uptak
transferrin
observ
strengthen
conclus
entri
mediat
clathrin
pathway
although
commonli
use
marker
indic
uptak
macropinocytosi
dextran
like
enter
cell
pathway
particip
fluidphas
uptak
certainli
result
cytochalasind
show
dextran
enter
bhk
cell
use
actinindepend
pathway
although
actin
filament
disrupt
cytochalasind
dextran
uptak
appear
unaffect
see
fig
nevertheless
figur
show
h
h
post
uptak
colocalis
cointernalis
label
dextran
also
suggest
may
use
macropinocytosi
macropinocytosislik
mechan
enter
bhk
cell
result
describ
show
infect
bhk
cell
occur
via
clathrinindepend
entri
mechan
share
certain
characterist
macropinocytosi
macropinosom
fuse
lysosom
recycl
content
back
extracellular
space
like
via
earli
recyclingendosom
therefor
investig
whether
deliv
compart
entri
internalis
minut
cell
fix
process
confoc
microscopi
use
detect
internalis
viru
earli
recyclingendosom
label
incub
cell
label
transferrin
final
minut
viru
uptak
ie
minut
cell
fix
altern
cell
doubl
label
viru
marker
lateendosom
lysosom
use
mab
figur
show
repres
cell
experi
minut
viru
uptak
littl
viru
colocalis
transferrin
observ
fig
similarli
time
investig
viru
colocalis
transferrin
observ
data
shown
result
show
first
h
entri
appear
enter
earli
recyclingendosom
support
conclus
cme
requir
infect
similarli
minut
postuptak
viru
colocalis
data
shown
contrast
h
h
postentri
observ
colocalis
lamp
fig
h
post
uptak
viru
judg
colocalis
result
consist
uptak
mechan
deliv
posit
compart
lateendosomeslysosom
without
need
first
pass
earlyendosom
infect
bluetongu
viru
acid
activ
inhibit
rais
endosom
ph
consist
observ
forzan
et
al
conclud
infect
vero
hela
cell
mediat
cme
capsid
disassembl
membran
penetr
occur
within
earlyendosom
report
confirm
activ
endosom
acidif
requir
infect
bhk
cell
howev
contrast
previou
studi
found
clathrin
pathway
major
entri
rout
use
infect
bhk
cell
conclus
base
number
observ
includ
although
low
endosom
ph
shown
essenti
infect
kinet
deliveri
acid
compart
slower
expect
uptak
clathrin
pathway
entri
colocalis
transferrin
commonli
use
marker
cme
cellentri
infect
inhibit
express
three
differ
dn
inhibitor
cme
furthermor
eipa
cytochalasind
shown
inhibit
uptak
uptak
transferrin
indic
transferrin
internalis
differ
endocyt
pathway
observ
suggest
entri
bhk
cell
deliv
acid
compart
via
clathrin
independ
rout
one
possibl
rout
uptak
via
caveola
undergo
fusion
earlyendosom
howev
failur
dndynamin
inhibit
entri
infect
bhk
cell
suggest
viru
uptak
independ
caveola
conclus
support
show
infect
inhibit
cholesterol
deplet
disrupt
sever
lipidraft
depend
process
includ
caveolaemedi
endocytosi
anoth
clathrinindepend
uptak
rout
lead
acid
endosom
clicgeec
clathrin
independ
carriersgpiap
enrich
endocyt
compart
pathway
howev
contrast
entri
mechan
use
infect
bhk
cell
clicgeec
pathway
highli
sensit
cholesterol
deplet
therefor
unlik
mediat
uptak
recent
studi
shown
vesicl
deriv
number
clathrinindepend
pathway
fuse
earli
lateendosom
virus
use
mechan
infecti
entri
exampl
lymphocyt
choriomening
viru
lcmv
kaposi
sarcoma
associ
herpesviru
kshv
internalis
clathrinindepend
mechan
result
viru
deliveri
lateendosom
without
first
pass
earlyendosom
howev
uptak
pathway
use
lcmv
appear
distinct
describ
entri
bhk
cell
sever
way
includ
lcmv
uptak
infect
block
inhibitor
macropinocytosi
entri
rout
use
kshv
appear
similar
describ
sinc
also
share
characterist
macropinocytosi
howev
unlik
bhk
cell
entri
mechan
entri
kshv
inhibit
dynasor
therefor
dynamin
independ
basi
viru
colocalis
dextran
sensit
eipa
actin
disrupt
bhk
cell
entri
rout
appear
close
relat
macropinocytosi
number
virus
includ
vaccinia
viru
coxsackieviru
hiv
kshv
echoviru
human
adenoviru
type
shown
exploit
macropinocytosi
macropinocytosislik
endocyt
pathway
cellentri
infect
macropinosom
deliv
content
late
endosom
compart
lateendosom
lysosom
without
need
earlyendosom
similarli
rout
describ
entri
bhk
cell
also
appear
bypass
earlyendosom
deliv
viru
late
endosom
compart
observ
suggest
infect
ie
acid
induc
membran
penetr
might
occur
within
lateendosom
lysosom
howev
yet
certain
compart
site
infect
intermedi
step
viru
traffick
plasma
membran
lateendosom
compart
known
possibl
viru
could
expos
low
ph
transit
involv
dynamin
macropinocytosi
clear
studi
investig
role
given
conflict
result
similarli
virus
use
macropinocytosi
infect
display
differ
sensit
dynamin
inhibit
studi
show
dn
mutant
aa
splice
variant
inhibit
uptak
infect
bhk
cell
dn
mutant
shown
inhibit
uptak
transferrin
see
fig
dextran
data
shown
indic
macropinocytosisfluidphas
uptak
cme
activ
bhk
cell
express
mutant
observ
consist
recent
studi
cao
et
al
show
differ
splice
variant
regul
differ
endocytosi
pathway
express
dn
mutant
aa
splice
variant
result
attenu
transferrin
dextran
uptak
contrast
uptak
inhibit
dynamin
inhibitor
dynasor
sinc
like
dynasor
inhibit
form
dynamin
observ
suggest
mechan
use
enter
bhk
cell
dynamin
depend
reli
form
dynamin
inhibit
dn
mutant
aa
splice
variant
conclus
describ
pathway
uptak
infect
bhk
cell
independ
clathrin
cholesterol
requir
dynamin
appear
deliv
viru
directli
lateendosomeslysosom
without
first
pass
earlyendosom
share
characterist
macropinocytosi
recent
forzan
et
al
report
infect
vero
hela
cell
mediat
cme
acidinduc
infect
occur
within
earlyendosom
henc
btv
join
increas
number
virus
appear
abl
use
one
endocyt
pathway
initi
infect
btv
infect
wide
varieti
cell
type
mammalian
host
includ
endotheli
cell
mononuclear
phagocyt
cell
dendrit
cell
varieti
leukocyt
like
broad
tropism
abil
btv
replic
evolutionari
distant
host
result
part
abil
use
multipl
entri
rout
initi
infect
moreov
btv
exist
least
three
differ
form
consid
infecti
includ
intact
viru
particl
infecti
subvir
particl
viruscor
differ
particl
type
differ
surfac
compon
may
therefor
also
use
differ
entri
mechan
infect
howev
entri
rout
use
btv
infect
natur
target
cell
relev
pathway
pathogenesi
anim
insect
host
requir
studi
